Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinoma

European Journal of Radiology

Volumn 66, Issue 1, 2008, Pages 88-94

  Pacella, Claudio M ^a   Stasi, Roberto ^a   Bizzarri, Giancarlo ^a   Pacella, Sara ^a   Graziano, Filomena Maria ^a   Guglielmi, Rinaldo ^a   Papini, Enrico ^a  

^a REGINA APOSTOLORUM HOSPITAL   (Italy)

Author keywords

Adrenocortical carcinoma; Metastases; Percutaneous laser ablation

Indexed keywords

CLINICAL LABORATORIES; DRUG DOSAGE; LASER ABLATION; PATIENT TREATMENT; TUMORS; ULTRASONIC EFFECTS;

ADRENOCORTICAL CARCINOMA (ACC); METASTASES; PERCUTANEOUS LASER ABLATION;

ONCOLOGY;

HYDROCORTISONE; MITOTANE;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SIZE; CASE REPORT; CAUSE OF DEATH; CUSHING SYNDROME; DRUG DOSE REDUCTION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERTENSION; INOPERABLE CANCER; LIVER METASTASIS; LOW LEVEL LASER THERAPY; MALE; PATIENT SAFETY; PERCUTANEOUS LASER ABLATION; PRIORITY JOURNAL; ULTRASOUND; WEIGHT REDUCTION;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; HUMANS; LASER THERAPY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOTANE; PALLIATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 41149121214     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.04.009     Document Type: Article

References (22)

1. Vaughan Jr. E.D. Diseases of the adrenal gland. Med Clin North Am 88 2 (2004) 443-466
2. Dackiw A.P., Lee J.E., Gagel R.F., and Evans D.B. Adrenal cortical carcinoma. World J Surg 25 7 (2001) 914-926
3. Ng L., and Libertino J.M. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169 1 (2003) 5-11
4. Icard P., Goudet P., Charpenay C., et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25 7 (2001) 891-897
5. Pommier R.F., and Brennan M.F. An eleven-year experience with adrenocortical carcinoma. Surgery 112 6 (1992) 963-970 [discussion 70-1]
6. Jensen J.C., Pass H.I., Sindelar W.F., and Norton J.A. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy. Arch Surg 126 4 (1991) 457-461
7. Bellantone R., Ferrante A., Boscherini M., et al. Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 122 6 (1997) 1212-1218
8. Tranberg K.G. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol 18 1 (2004) 125-145
9. Gillams A.R. Image guided tumour ablation. Cancer Imaging 5 (2005) 103-109
10. Pacella C.M., Bizzarri G., Francica G., et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol 16 11 (2005) 1447-1457
11. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235 3 (2005) 728-739
12. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 1 (1981) 207-214
13. Sacks D., McClenny T.E., Cardella J.F., and Lewis C.A. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14 9 Pt 2 (2003) S199-S202
14. Jacques S.L. Laser-tissue interactions. Photochemical, photothermal, and photomechanical. Surg Clin North Am 72 3 (1992) 531-558
15. Pacella C.M., Valle D., Bizzarri G., et al. Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: results of a phase II study. Acta Oncol 45 1 (2006) 77-83
16. Vogl T.J., Lehnert T., Eichler K., Proschek D., Floter J., and Mack M.G. Adrenal metastases: CT-guided and MR-thermometry-controlled laser-induced interstitial thermotherapy. Eur Radiol 17 (2007) 2020-2027
17. Wood B.J., Abraham J., Hvizda J.L., Alexander H.R., and Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 97 3 (2003) 554-560
18. Mayo-Smith W.W., and Dupuy D.E. Adrenal neoplasms: CT-guided radiofrequency ablation-preliminary results. Radiology 231 1 (2004) 225-230
19. Walser E.M. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with a tumor size of 4 cm or smaller: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol 16 (2005) 1427-1429
20. Rhim H., Goldberg S.N., Dodd III G.D., et al. Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. RadioGraphics 21 (2001) S17-S39
21. Mahnken A.H., Rohde D., Brkovic D., Gunther R.W., and Tacke J.A. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results. Acta Radiol 46 2 (2005) 208-214
22. Pacella C.M., Bizzarri G., Cecconi P., et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 219 3 (2001) 669-678